US › Healthcare

Zivo Bioscience Inc (ZIVO)

US · Healthcare · Biotechnology

$4.000.00%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Net profit
$-951,489
Profit YoY
+77.4%
EPS
$-0.27
EPS estimate
$-0.36

EPS came in at -0.27 against a street estimate of -0.36 — a beat of 25.0%.

Key statistics

Market cap
$16.6M
Forward P/E
0.0
P/B
20.76
Book value
$-0.86
EPS (TTM)
$-2.18
52-week high
$19.65
52-week low
$1.11
50-day MA
$4.19
200-day MA
$7.45
Beta
0.18

Analyst view

Analysts rate Zivo Bioscience Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $12.00.

Shareholding

Insiders
48.02%
Institutions
0.11%

Largest institutional holders

FundStake
CoreCap Advisors, LLC0.10%
Huntington National Bank0.00%
Kohmann Bosshard Financial Services, LLC0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Zivo Bioscience Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.